Skip to main content
SpringerLink
Log in

Prognosis of testicular tumour since the introduction of complex therapy

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Change of approach in dealing with testicular carcinoma has made it necessary to set up a central organization covering a larger geographic area in Hungary where 242 patients had been treated since 1980. Progress in the development of therapy-oriented methods cleared the way for reliable and accurate stage determination. Data analysis seems to indicate that correct therapeutic principles combined with plenty of surgical, radiological and chemotherapeutic experience may contribute a lot to improving the pathologic prospects. The mortality rates for the pure seminoma group and for the non-seminomatous plus mixed-cell group of patients were 7.5% and 26.5%, respectively. The results promise additional chances—even with increasing morbidity—to reduce the mortality rate and the incidence of complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

beta-HCG:

basic unit of human choriogonadotropin

RLA:

retroperitoneal lymphadenectomy

AFP:

alpha1-foetoprotein

VACAD:

Vincristine, Actinomycin, Cyclophosphamide, Adriablastin

VPB:

Vinblastin, Cis-platin, Bleomycin

References

  1. Ball, D., Barrett, A., Peckham, M. J.: The management of metastatic seminoma testis.Cancer, 50, 2289 (1982).

    Article  PubMed  CAS  Google Scholar 

  2. Batata, M. A., Chu, F. C. H., Hilaris, B. S., Papantoniou, P. A., Whitmore, W. F., Golbey, R. B.: Therapy and prognosis of testicular carcinomas in relation to TNM classification.Int. J. Rad. Oncol. Biol. Phys., 8, 1287 (1982).

    CAS  Google Scholar 

  3. Davies, J. M.: Testicular cancer in England and Wales: Some epidemiological aspects.Lancet, I, 928 (1981).

    Article  Google Scholar 

  4. Donohue, J. P., Rowland, R. G.: Complication of retroperitoneal lymph node dissection.J. Urol., 125, 338 (1981).

    PubMed  CAS  Google Scholar 

  5. Einhorn, L. H., Donohue, J. P.: Cis-diaminedichloroplatínum, vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer.Ann. Intern. Med., 87, 293 (1977).

    PubMed  CAS  Google Scholar 

  6. Farkas, L., Frang, D., Csővári, M., Pácsa, S., Székely, J. Jr.: The significance of tumour markers in the diagnosis of testicular cancer and in tracing the therapeutic effect (in Hung.).Orv. Hetil., 125, 1747 (1984).

    PubMed  CAS  Google Scholar 

  7. Frang, D.: Tumorous diseases of the male genitals (in Hung.). Medicina Könyvkiadó, Budapest 1984, pp. 23–41.

    Google Scholar 

  8. Hegedüs, M., Farkas, L., Székely, J. Jr., Török, A., Frang, D.: Diagnostic accuracy of lymphangiography in the demonstration of histologically verified retroperitoneal lymph node metastases of testicular tumours.Int. Urol. Nephrol., 17, 245 (1985).

    Article  PubMed  Google Scholar 

  9. Hendry, W. F., Barrett, A., McElwain, T. J., Wallace, D. M., Peckham, M. J.: The role of surgery in the combined management of metastases from malignant teratomas of testis.Br. J. Urol., 52, 38 (1980).

    Article  PubMed  CAS  Google Scholar 

  10. Huben, R. P., Williams, P. D., Pontes, J. E., Panahon, A. M., Murphy, G. P.: Seminoma at Roswell Park, 1970 to 1979. An analysis of treatment failuresCancer, 53, 1451 (1984).

    Article  PubMed  CAS  Google Scholar 

  11. Jaeger, N., Weissbach, L., Altwein, J. E., Kreuser, E.: Primary lymphadenectomy or primary chemotherapy in advanced metastatic testicular tumor?Eur. Urol., 9, 329 (1983).

    PubMed  CAS  Google Scholar 

  12. Javadpour, N., Ozols, R. F., Anderson, T., Barlock, A. B., Wesley, R., Young, R. C.: A randomized trial of cytoreductive surgery followed by chemotherapy versus chemotherapy alone in bulky stage III testicular cancer with poor prognostic features.Cancer, 50, 2004 (1982).

    Article  PubMed  CAS  Google Scholar 

  13. Johnson, D. E.: Retroperitoneal lymphadenectomy: Indications, complications and expectations. In: Tumors of the Male Genital System. Springer Verlag, Berlin-Heidelberg-New York 1977, p. 221.

    Google Scholar 

  14. Kuhn, E., Bőhm, K., Molnár, Z., Thán, Z., Varga, Gy.: Die Bedeutung der Röntgenuntersuchungen in der Beurteilung der Ausdehnung der malignen Hodentumoren.Strahlentherapie, 150, 456 (1975).

    PubMed  CAS  Google Scholar 

  15. Lindsey, C. M., Glenn, J. F.: Germinal malignancies of the testis: Experience, management and prognosis.J. Urol., 116, 59 (1976).

    PubMed  CAS  Google Scholar 

  16. Mostofi, F. K.: Epidemiology and pathology of tumors of human testis. In: Tumors of the Male Genital System. Springer Verlag, Berlin-Heidelberg-New York 1977, p. 176.

    Google Scholar 

  17. Mostofi, F. K.: Pathology of germ cell tumors of testis. A progress report.Cancer, 45, 1735 (1980).

    PubMed  CAS  Google Scholar 

  18. Oliver, R. T. D.: Testicular germ cell tumors—a model for a new approach to treatment of adult solid tumors.Postgrad. Med. J., 61, 123 (1985).

    PubMed  CAS  Google Scholar 

  19. Oliver, R. T. D.: Curable cancers: Testis cancer.Br. J. Hosp. Med., January, 23 (1984).

  20. Ostrow, S. S.: The management of nonseminomatous testicular cancer: Current therapy and future directions.Am. J. Med. Sci., 285, 24 (1983).

    Article  PubMed  CAS  Google Scholar 

  21. Peckham, M. J.: An appraisal of the role of radiation therapy in the management of nonseminomatous germ cell tumors of the testis in the era of effective chemotherapy.Cancer Treat. Rep., 63, 1653 (1979).

    PubMed  CAS  Google Scholar 

  22. Staubitz, W. J.: Management of testicular tumors.J. Am. Med. Assoc., 166, 751 (1958).

    PubMed  CAS  Google Scholar 

  23. Staubitz, W. J.: Surgical treatment of nonseminomatous germinal testis tumors. In: Tumors of the Male Genital System. Springer Verlag, Berlin-Heidelberg-New York 1977.

    Google Scholar 

  24. Weissbach, L., Boedefeld, E. A., Oberdörster, W., Vahlensieck, W.: Therapy in state I non-seminomatous testicular tumor. A critical review of currents strategies.Eur. Urol., 10, 1 (1984).

    PubMed  CAS  Google Scholar 

  25. Vugrin, D., Whitmore, W. F.: The role of chemotherapy and surgery in the treatment of retroperitoneal metastases in advanced nonseminomatous testis cancer.Cancer, 55, 1874 (1985).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Semmelweis University Medical School, Budapest, Hungary

    D. Frang, L. Farkas, F. Götz & J. Székely Jr.

  2. Department of Urology, University Medical School, Pécs, Hungary

    D. Frang, L. Farkas, F. Götz & J. Székely Jr.

Authors
  1. D. Frang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Farkas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Götz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Székely Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frang, D., Farkas, L., Götz, F. et al. Prognosis of testicular tumour since the introduction of complex therapy. International Urology and Nephrology 21, 81–89 (1989). https://doi.org/10.1007/BF02549905

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02549905

Keywords

Search

Navigation